Le Lézard
Classified in: Health
Subject: MAT

IM Cannabis to Host a Live Investor Webcast on December 10, 2019


TORONTO and GLIL YAM, Israel, Dec. 4, 2019 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world's pioneering medical cannabis companies with operations across Europe,  is pleased to announce that Oren Shuster, Chief Executive Officer, will present live at Grit Capital's Webcast Series on December 10, 2019 at 11:00am ET/8:00am PT.

Date:

December 10, 2019

Time:

11:00am ET/8:00am PT

Format:

Live 20 minutes presentation & 10 minutes Q&A session

Link:

https://event.on24.com/wcc/r/2137262/16F9A018E6438E7C82E6E26986BD239C

 

This will be a live and interactive online event where investors are invited to ask the Company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.

Recent Company Highlights

About IM Cannabis Corp.

IMC is an international medical cannabis company, and a well-known Israeli brand of medical cannabis products. In Europe, IMC is establishing a medical cannabis operation first with its distribution subsidiary in Germany and augmented by strategic agreements with certified EU-GMP Standard suppliers, making it one of the only medical cannabis companies with fully integrated operations in Europe. IMC intends to leverage its operational experience and brand to establish a foothold in emerging medical cannabis markets including Germany, Portugal and Greece. IMC's core Israeli business includes offering branding, know-how and other intellectual property-related services to the Israeli medical cannabis market. Its key assets in Israel include commercial agreements with licensed producers and an option to purchase licensed entities. IMC has developed proprietary processes in its operations and is active in developing innovative technology for global medical cannabis consumers.

SOURCE IM Cannabis Corp.


These press releases may also interest you

at 20:00
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, announce...

at 20:00
InterDent announces that most Oregon offices will remain open to maintain access to preventive services for Oregon communities. Capitol Dental Care will continue to partner with Oregon county organizations to provide support for communities affected...

at 19:05
FOR EU TRADE AND MEDICAL MEDIA ONLY. NOT FOR DISTRIBUTION IN BENELUX. The Janssen Pharmaceutical Companies of Johnson & Johnson announced yesterday interim results from the CHRYSALIS study (NCT02609776) evaluating amivantamab, a fully human...

at 17:30
Aimee Daramus, Psy.D., clinical psychologist, has been quoted on topics related to mental illness in Bustle, HuffPost, wellandgood.com, Mic.com, and several other media outlets. On Sept. 15, 2020, Callisto Press released her first book, Understanding...

at 14:01
Eli Lilly and Company today announced Verzenio® (abemaciclib) in combination with standard adjuvant endocrine therapy (ET) significantly decreased the risk of breast cancer recurrence by 25 percent compared to standard adjuvant ET alone for people...

at 12:35
AstraZeneca and Merck , known as MSD outside the United States and Canada, today announced final results from the Phase III PROfound trial that showed LYNPARZA (olaparib) demonstrated a statistically significant and clinically meaningful improvement...



News published on 4 december 2019 at 07:00 and distributed by: